Skip to main content
Clinical Trials/NCT00949793
NCT00949793
Completed
Phase 1

In Vivo Confocal Endomicroscopy of the Brain

Carl Zeiss Surgical GmbH1 site in 1 country30 target enrollmentMarch 2008
ConditionsBrain Neoplasms

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Brain Neoplasms
Sponsor
Carl Zeiss Surgical GmbH
Enrollment
30
Locations
1
Primary Endpoint
To test of the ability of the surgeon to obtain interpretable images during surgery.
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The purpose of the study is to test the feasibility of obtaining interpretable in vivo endomicroscopy images which can be compared with traditional histopathology.

Hypothesis: That a rigid confocal endomicroscope can be used during neurosurgery to provide in vivo histology that enables differentiation of tumour tissue from normal adjacent brain tissue.

Detailed Description

Confocal endomicroscopy is a medical imaging modality that allows real-time microscopy to be performed on living tissue in vivo. It is already in clinical use in the fields of gastroenterological endoscopy, laparoscopy, dermatology, gynecology and respiratory medicine. This study represents the first time that confocal endomicroscopy will be evaluated for intraoperative imaging in neurosurgery. The procedure involves a small endoscope which is placed gently into contact with the brain, providing significant in vivo magnification on a scale similar to that obtained by the pathology laboratory microscope. The captured confocal images will be compared with corresponding histology (tissue that is being removed as part of the indicated neurosurgical procedure). The images will be visually compared among each other and with histology images to detect possible clinically relevant information.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
November 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Carl Zeiss Surgical GmbH

Eligibility Criteria

Inclusion Criteria

  • All patients with neurosurgical pathology requiring surgery in which tumor resection might be evaluated by using biopsy.

Exclusion Criteria

  • Pregnant women
  • Inability to give informed consent
  • History of allergy to fluorescein
  • Patients on beta-blockers or ACE inhibitors

Outcomes

Primary Outcomes

To test of the ability of the surgeon to obtain interpretable images during surgery.

Time Frame: During surgery

Secondary Outcomes

  • To correlate the in vivo endomicroscopy images with traditional histopathology.(one week)
  • To evaluate the usability of the device in the OR environment.(During surgery)

Study Sites (1)

Loading locations...

Similar Trials